Supporting clinical sciences

Postal address
Laarbeeklaan 101
1090
Brussels
Belgium

Research output

  1. CAM-H2 effectively targets and treats HER2 positive brain lesions: A comparative preclinical study with trastuzumab

    Research output: Contribution to journalMeeting abstract (Journal)Research

  2. Combining Bismuth-213 with Nanobodies: Finding the Perfect Match for Targeted Alpha Therapy

    Research output: Chapter in Book/Report/Conference proceedingConference paperResearch

  3. The Therapeutic Potential of Anti-HER2 2Rs15d Nanobody Labeled with 225Ac – an In Vitro and In Vivo Evaluation

    Research output: Chapter in Book/Report/Conference proceedingConference paperResearch

View all (78) »

Activities

  1. Use of Nanobodies for medical applications and activities of the spin-off company Camel-IDS

    Activity: Talk or presentationTalk or presentation at a workshop/seminar

  2. Targeted Radionuclide Therapy with Nanobodies

    Activity: Talk or presentationTalk or presentation at a workshop/seminar

  3. An 131I-labeled camelid single-domain antibody fragment to treat HER2-overexpressing cancer

    Activity: Talk or presentationTalk or presentation at a conference

View all (24) »

Prizes

  1. Alavi-Mandell Award from Journal of Nuclear Medicine

    Prize: Prize (including medals and awards)

  2. Travel Stipend WMIC - Best Abstract

    Prize: Prize (including medals and awards)

  3. Award of the Fonds Germaine Eisendrath Dubois (FGED)

    Prize: Prize (including medals and awards)

View all (7) »

ID: 118617